| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/24/2006 | CN1775809A Bt CrylA antibody, and its preparing method and special antigen and use |
| 05/24/2006 | CN1775808A Anti CD19 engineered antibody for target conjugated lymphocyte, leuco cyte and its use |
| 05/24/2006 | CN1775807A Haliotis diver sicilor supertexta immunofactor specific antibody preparing and its detecting method |
| 05/24/2006 | CN1775806A 2, 4, 6-trichlorophen artificial antigen, and its preparing method and use |
| 05/24/2006 | CN1775805A 2, 4-dichlorophen artificial antigen, and its preparing method and use |
| 05/24/2006 | CN1257271C Serine proteinase and coded sequence thereof |
| 05/23/2006 | US7049426 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049416 Phosophoinositoglycan binding proteins |
| 05/23/2006 | US7049413 MAGE-A3 peptides presented by HLA class II molecules |
| 05/23/2006 | US7049412 Genetic engineered nucleic acids codes these enzymes; therapy for bone disorders; monoclonal antibodies |
| 05/23/2006 | US7049411 Human anti-factor IX/IXa antibodies |
| 05/23/2006 | US7049410 Antibody for use in the detection of tumors |
| 05/23/2006 | US7049409 Heregulin-like factor antibodies |
| 05/23/2006 | US7049408 Preferential polypeptide; for use in the diagnosis and treatment of arthritis |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049282 Preventing immunologic damage in a variety of diseases and conditions including autoimmune diseases by administering a peptide fragment of the CH2 or CH3 domain of IgG or of the CH2, CH3 or CH4 domain IgM; preventing hyperacute xenograft |
| 05/23/2006 | US7049136 Redirection of cellular immunity by receptor chimeras |
| 05/23/2006 | US7049126 Human serine protease |
| 05/23/2006 | US7049119 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2006 | US7049118 isolated and purified protein and complimentary DNA; culturing a host cell to express the regulatory protein; biodrugs; enzyme inhibitors; anticarcinogenic, antidiabetic agents; nervous system disorders; chronic obstructive pulmonary disorder |
| 05/23/2006 | US7049101 Enzymes having high temperature polymerase activity and methods of use thereof |
| 05/23/2006 | US7049085 Monoclonal antibody for use in passive immunization against poisoning/intoxication by botulin toxins |
| 05/23/2006 | US7049079 Coupling factor 6 inhibitor and potentiator and use thereof |
| 05/23/2006 | US7049075 Deoxyribonuclease IIβ proteins and cDNAs |
| 05/23/2006 | US7049063 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/23/2006 | US7049060 Secreted by hybridoma cell lines; hepatitis C virus (HCV) |
| 05/23/2006 | US7048923 Antibodies to mitogenic oxygenases |
| 05/23/2006 | US7048211 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 05/23/2006 | CA2201865C Laminin chains: diagnostic and therapeutic use |
| 05/18/2006 | WO2006052900A2 Targeted innate immunity |
| 05/18/2006 | WO2006052591A2 Anti-properdin antibodies, and methods for making and using same |
| 05/18/2006 | WO2006052534A2 Expansion of nk cells and therapeutic uses thereof |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051145A1 Competitive elisa for the detection of gluten hydrolysate and applications thereof |
| 05/18/2006 | WO2006050964A2 Indinavir derivatives useful in immunoassay |
| 05/18/2006 | WO2006050949A2 Superagonistic anti-cd28 antibody |
| 05/18/2006 | WO2006050667A1 MONOCLONAL ANTIBODIES AGAINST APOPTOSIS-RELATED ACETYLCHOLINESTERASE (AR-AChE) AND USE THEREOF |
| 05/18/2006 | WO2006050571A1 Chlamydia antigens and uses thereof |
| 05/18/2006 | WO2006033675A3 Bacillus anthracis spore specific antobodies |
| 05/18/2006 | WO2006024867A3 Method for improved transgene expression |
| 05/18/2006 | WO2005117941A3 Methods and compositions for the treatment of polycystic diseases |
| 05/18/2006 | WO2005116071A3 Snares for pathogenic or infectious agents and uses related thereto |
| 05/18/2006 | WO2005115456A3 METHODS OF MODULATING THE REPRODUCTIVE ENDOCRINE SYSTEM BY MODULATION OF TNFαACTIVITY |
| 05/18/2006 | WO2005113587A3 Gene products expressed differentially in tumors and use thereof |
| 05/18/2006 | WO2005108988A3 Real time method of detecting acute inflammatory conditions |
| 05/18/2006 | WO2005108432A3 Cd80 (b7-1) binding peptides and uses thereof |
| 05/18/2006 | WO2005099776A3 Steroid sparing agents and methods of using same |
| 05/18/2006 | WO2005087806A3 Cd38 splice variant and uses thereof |
| 05/18/2006 | WO2005079489A3 Method of treating cancer and identifying novel anti-ancer compounds |
| 05/18/2006 | WO2005077044A3 Rational design and engineering of proteins and peptides for immunomodulation |
| 05/18/2006 | WO2005056601A3 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse? |
| 05/18/2006 | WO2004110355A3 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 05/18/2006 | WO2004109292A3 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 05/18/2006 | WO2004006837A3 Mesothelin vaccines and model systems |
| 05/18/2006 | US20060107351 Cell visual characteristic-modifying sequences |
| 05/18/2006 | US20060107345 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| 05/18/2006 | US20060106204 Bifunctional energy-reversible acyl-compositions |
| 05/18/2006 | US20060106203 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; pharmacokinetics; surface plasmon resonance; host cell |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106201 Novel hemopoietin receptor protein, NR12 |
| 05/18/2006 | US20060106090 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105470 For detecting early conception factor in a body fluid from an animal comprising the antibodies which specifically bind early conception factor |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105427 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/18/2006 | US20060105403 Braca1/acc alpha molecular complexes, diagnostic and therapeutic applications |
| 05/18/2006 | US20060105401 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion |
| 05/18/2006 | US20060105400 Elisa kits for detecting collagenase 3 as a proenzyme and in an activated form in body fluids and cell culture supernatants |
| 05/18/2006 | US20060105399 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time |
| 05/18/2006 | US20060105396 Novel epithelial tissue imaging agent |
| 05/18/2006 | US20060105389 Solubilizing inclusion bodies in a detergent to release the ScFv antibody; oxidizing to form disulfide bonds; removing the detergent;precipitating the oxidized ScFv antibodies; dissolving the precipitated ScFv antibodies in a denaturing solution; immobilizing on solid support; renaturing, elution |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105346 Human prostaglandin FP receptor variants and methods of using same |
| 05/18/2006 | US20060105013 Osteopontin-coated surfaces and methods of use |
| 05/18/2006 | US20060104992 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating HIV |
| 05/18/2006 | US20060104990 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 05/18/2006 | US20060104988 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 05/18/2006 | US20060104987 Rhesus D antigen encoded by a nucleic acid molecule carrying one or more specific missense mutations used for determining whether a patient that is in need of a blood transfusion needs to be transfused with RhD negative blood |
| 05/18/2006 | US20060104981 Prophylactic/therapeutic agent for cancer |
| 05/18/2006 | US20060104980 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 05/18/2006 | US20060104978 Methods and compositions for PDGF-C activation and inhibition |
| 05/18/2006 | US20060104977 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 05/18/2006 | US20060104976 Identification and use of high efficacy vaccine antigens which modulate antigen presenting cells |
| 05/18/2006 | US20060104974 CD147 binding molecules as therapeutics |
| 05/18/2006 | US20060104973 Inhibitors of Nogo Receptor (NgR)-p75 binding are used to reduce NgR-p75 binding mediated axon growth inhibition; myelins; for drug screening; cell-free; reducing myelin-mediated inhibition of axon regeneration |
| 05/18/2006 | US20060104972 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 05/18/2006 | US20060104971 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 05/18/2006 | US20060104949 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | US20060104898 Targeting ligands comprising an amino acid sequence for guided targeting of irradiated glioma, a melanoma, and a lung carcinoma |
| 05/18/2006 | DE10063879B4 Nucleinsäuren, die vacuoläre Invertasen codieren, Pflanzenzellen und Pflanzen, die diese enthalten sowie ihre Verwendung Nucleic acids encoding the vacuolar invertase, plant cells and plants containing them and their use |
| 05/18/2006 | CA2587494A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 05/18/2006 | CA2586913A1 Targeted innate immunity |
| 05/18/2006 | CA2586661A1 Antibodies against tenascin-c |
| 05/18/2006 | CA2586313A1 Ovr110 antibody compositions and methods of use |
| 05/18/2006 | CA2586285A1 Antibody induced cell membrane wounding |